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Short
report
The sac-4 gene of Neisseria gonorrhoeae and
co-existing chlamydial infection
D J Phillips, C Patrizio, A Moyes, H Young
Background/objectives: Recently, the sac-4 gene in Neisseria gonorrhoeae was postulated to
increase the risk of developing mixed gonococcal and chlamydial infection. The aims of this study
were to determine the frequency of the sac-4 gene in a larger sample of isolates of diVerent sero-
vars and to assess the prevalence of sac-4 in gonococcal isolates from patients with and without
coexisting chlamydial infection.
Methods: Isolates from 259 episodes of gonorrhoea were tested by a PCR assay for the sac-4
gene. The presence of co-existing chlamydial infection was determined from both laboratory and
GUM clinical records.
Results: The overall prevalence of sac-4 was 57.5% (149/259). The prevalence was not the same
in all serovars and ranged from 34.9% in serovar 1B2 to 100% in serovar 1B18. Exact logistic
regression analysis indicated significant diVerences in sac-4 prevalence in isolates of diVerent
serovars. The prevalence of sac-4 was 69.5% (41/59) in gonococcal isolates from patients with
co-existing chlamydial infection compared with 57.9% (62/107) for those without chlamydial
infection. Exact logistic regression analysis showed that the slightly increased sac-4 prevalence
among chlamydia positive patients (p=0.2) virtually disappeared when serovar status was taken
into account (p>0.9).
Conclusion: The sac-4 gene of the gonococcus does not increase the risk for mixed chlamydial
infection.
(Sex Transm Inf 2000;76:400–402)
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Introduction
Dual infection of the genital tract with Chlamy-
dia trachomatis and Neisseria gonorrhoeae is well
established with a prevalence ranging from
14–43% but little is known of the epidemiology
and associated clinical features of such co-
existing infections.1 Recently a gene, sac-4, was
found in a high proportion of gonococcal
isolates from patients with coexisting chlamy-
dial infection and it was postulated that sac-4
increased the risk of development of mixed
gonococcal and chlamydial infection.2 This
gene conferred stable (not lost on subculture)
complement factor C1q dependent serum
resistance in gonococci.3 4
The aims of this study were to use the
polymerase chain reaction (PCR) assay de-
scribed by Nowicki et al 2 3 to determine the
frequency of the sac-4 gene in a larger range of
isolates of diVerent serovars; and to assess the
prevalence of sac-4 in gonococcal isolates from
patients with and without coexisting chlamy-
dial infection.
Materials and methods
PATIENTS AND ISOLATES
Isolates from 259 episodes of gonorrhoea in 80
female and 179 male patients attending a
genitourinary medicine (GUM) clinic were
studied. The isolates represented 19 diVerent
serovars. The prevalence of sac-4 was deter-
mined for each of the common serovars,
arbitrarily defined as comprising more than 15
isolates each: serovars represented by less than
15 isolates were grouped together as “other
1A” and “other 1B” serovars (see table 1). The
presence of coexisting chlamydial infection was
determined from laboratory and GUM clinical
records.
EXTRACTION OF DNA AND PCR ASSAY
The growth from an overnight plate culture
was mixed with 1 ml of saline, centrifuged,
resuspended in 200 µl of distilled water, and
heated for 20 minutes at 100°C. After cooling
and centrifugation the supernatant from
each tube was stored at −20°C for PCR
testing.
Primers were as described by Nowicki et al4:
Primer A, 5' TAT CTG CAG CAT CTC CTT
TCC AAC C 3'
Primer B, 5' TAG GAA TTC CTC TGA AGG
TTA CGG 3'.
Table 1 Sac-4 prevalence in various gonococcal serovars isolated from patients with and
without coexisting chlamydial infection
Serovar
Sac-4+ prevalence
Overall
Known chlamydia
positive patients*
Known chlamydia
negative patients*
1A2 80% (20/25) 69.2% (9/13) 100% (5/5)
Other 1A† 44.5% (8/18) 40% (2/5) 57% (4/7)
1B2 34.9% (22/63) 42.9% (3/7) 32.1% (9/28)
1B3 63.3% (19/30) 60% (6/10) 71.4% (10/14)
1B6 42.6% (20/47) 50% (1/2) 40.9% (9/22)
1B18 100% (16/16) 100% (7/7) 100% (8/8)
1B31 91.7% (33/36) 100% (8/8) 93.8% (15/16)
Other 1B‡ 45.8% (11/24) 71.4% (5/7) 28.6% (2/7)
Total 57.5% (149/259) 69.5% (41/59) 57.9% (62/107)
*Chlamydia status was not known for 93 patients.
†18 isolates representing serovars 1A1, 1A4, 1A5, 1A6, 1A8, and 1A21.
‡24 isolates representing serovars 1B1, 1B4, 1B7, 1B8, 1B13, 1B23, and 1B32.
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A volume of 2 µl of DNA template was
added to 100 µl reaction mix (50 mM KCl, 10
mM TRIS-HCl, 15 mM MgCl2 and 0.1% Tri-
ton X-100) containing 0.5 units of Taq
Polymerase (Promeg Corporation, Southamp-
ton), 20 µmol of each DNTP (Promega), and
0.1 µmol of each primer (Oswel DNA Service,
Southampton). The reaction mixture was
overlaid with two drops of liquid paraYn. The
amplification reaction consisted of 30 cycles of
1 minute denaturation at 92°C, 1 minute
annealing at 55°C, and 1 minute extension at
72°C. An aliquot of 20 µl was removed for
electrophoretic analysis on a 2% agarose gel. A
band corresponding to 344 base pairs indicated
a positive sac-4 result.
A sac-4 negative and positive control strain
were included in each run.
STATISTICAL ANALYSIS
This was performed using exact logistic
regression.
Results
PCR analysis showed that 149 isolates (57.5%)
were sac-4+ (each strain gave a single band cor-
responding to 344 base pairs) and 110 isolates
(42.5%) were sac-4− (no bands present). An
example of a typical gel is shown in figure 1.
The prevalence of sac-4 ranged from 34.9% in
serovar 1B2 to 100% in serovar 1B18 (table 1).
The data in table 1 were analysed by exact
logistic regression, with sac-4 as the response
(dependent) variable, and chlamydia status
and gonococcal serovar as independent (ex-
planatory) factors with two and eight levels
respectively. Comparing chlamydia positive
with chlamydia negative patients unadjusted
for serovar gave an odds ratio = 1.65, CI
(0.8,3.47) p=0.2. This indicates that overall a
higher prevalence of sac-4 was observed in
gonococcal isolates from chlamydia positive
patients than in isolates from chlamydia
negative patients but the diVerence was not
statistically significant. Comparing the preva-
lence of sac-4 in gonococcal isolates from
chlamydia positive patients with chlamydia
negative patients adjusted for gonococcal sero-
var gave an odds ratio = 1.06 CI (0.42,2.6)
p>0.9. Thus the slight excess of sac-4 preva-
lence in gonococcal isolates from chlamydia
positive patients virtually disappears when the
serovar of the infecting gonococcal isolate is
taken into account.
Comparing the eVects of gonococcal serovar
adjusted for the chlamydia status of the patient,
the odds ratios compared with serovar 1A2
were: other 1A serovars 0.19 CI (0.01–1.44);
1B2 0.14 CI (0.01–0.74); 1B3 0.44 CI (0.06–
2.29); 1B6 0.11 CI (0.002–1.06); 1B18 unde-
fined (this group had 100% prevalence for sac-
4); 1B31 4.34 CI 0.32–251.66); other 1B 0.33
(0.05–1.84). These results indicate significant
diVerences in sac-4 prevalence between the
serovar groups taking into account the chlamy-
dia status of the patients. Exact logistic
regression analysis for interaction between
chlamydia status and gonococcal serovar
yielded a p value of 0.05. Thus there is no evi-
dence for diVerences between serovar groups in
the comparison of sac-4 prevalences between
the chlamydia positive and chlamydia negative
patients.
Similar results were obtained using approxi-
mate logistic regression including the subjects
with unknown chlamydia status.
Discussion
The majority of isolates, 57.5% (149/259) in
our local population of gonococci, were sac-4
positive. However, the prevalence of sac-4 was
not significantly higher (p=0.2) in gonococcal
isolates from patients with coexisting chlamy-
dial infection (69.5%) than in those without
(57.9%). These findings suggest that sac-4 does
not increase the risk of developing mixed infec-
tion with C trachomatis. Our findings diVer
from those of Nowicki et al3 who found sac-4 in
71% (10/14) of gonococcal strains isolated
from patients with mixed gonococcal and
chlamydial infection and 7% (1/14) in isolates
from patients with gonococcal infection only.
Using exact logistic regression analysis we have
shown that there are significant diVerences in
the prevalence of sac-4 between certain serov-
ars.
Both epidemiological and biological factors
may play a part in the occurrence of coexisting
gonococcal and chlamydial infection. However
our findings do not support a biological role for
sac-4 in the development of mixed infection.
We are grateful to Hannah Wills for checking records for coex-
isting gonococcal and chlamydial infections and to Dr John
DuVy, director of Statlab Statistical Laboratory, Department of
Figure 1 A typical gel showing products from the PCR assay for the sac-4 gene of
Neisseria gonorrhoeae. Lane 1, blank; lane 2, DNA ladder; lane 3, negative control strain
3701−; lane 4, positive control strain 4520+; lane 5, strain 1319 (Sac-4−); lane 6, strain
2925 (Sac-4+); lane 7, strain 1395 (Sac-4−); lane 8, strain 1023 (Sac-4+); lane 9, strain
3256 (Sac-4−); lane 10, strain 4098 (Sac-4+); lane 11, strain 2850 (Sac-4−).
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Mathematics and Statistics, University of Edinburgh for
performing the statistical analysis.
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